Table 3.
Gene | Chr | Position | SNP | Effect allele | Control | Keratoconus | Odds ratio (95% CI) | Pa | ||
---|---|---|---|---|---|---|---|---|---|---|
N | EAF | N | EAF | |||||||
NRXN1 | 2 | 50635086 | rs13382330 | C | 8137 | 0.176 | 179 | 0.159 | 0.89 (0.67–1.19) | 0.420 |
CPLX2 | 5 | 175244097 | rs4242187 | T | 8150 | 0.097 | 179 | 0.070 | 0.70 (0.46–1.05) | 0.082 |
CSMD1 | 8 | 2799288 | rs143428993 | A | 8148 | 0.012 | 179 | 0.017 | 1.39 (0.61–3.14) | 0.435 |
ADAM12 | 10 | 127905962 | rs11244890 | A | 8156 | 0.211 | 179 | 0.196 | 0.91 (0.70–1.19) | 0.491 |
SMAD3 | 15 | 67467507 | rs12913547 | T | 8096 | 0.563 | 179 | 0.651 | 1.44 (1.16–1.80) | 0.001b |
WWOX | 16 | 78430702 | rs6564538 | T | 8156 | 0.110 | 179 | 0.117 | 1.07 (0.77–1.48) | 0.680 |
CDH13 | 16 | 83650510 | rs1035533 | G | 8150 | 0.190 | 179 | 0.201 | 1.07 (0.83–1.39) | 0.594 |
Chr, chromosome; EAF, effect allele frequency; SNP, single-nucleotide polymorphism; CI, confidence interval.
aP-values derived using logistic-regression analysis.
bP-values are statistically significant after Bonferroni’s correction.